CLINICAL_TRIALS
trial_result
· 2006-05-26
Clinical Trial Update: Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis [Phase 3]
Summary
A Phase 3 randomized trial evaluating three drug combinations for late-stage Gambiense human African trypanosomiasis has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Epicentre | Conditions: Trypanosomiasis, African | Phase 3 | Status: TERMINATED